This study reveals AGN as a multi-target GC therapy DAO modulation, IL-17A suppression, metabolic reprogramming, and programmed cell death induction. By integrating multi-omics and ethnopharmacology, we provide a framework for modernizing traditional herbal medicines into evidence-based therapies, positioning AGN as a potential candidate for precision GC treatment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: